Dicerna - Ownership and Business Overview

Life ScienceCompany

Dicerna Ownership

Who owns Dicerna?

Dicerna is owned by Novo Nordisk A/S. It was acquired on November 18, 2021.

Dicerna Business Overview

Where is Dicerna headquartered?

Dicerna is headquartered in Lexington, Massachusetts.

What is Dicerna’s revenue?

Dicerna disclosed revenue of 164M USD for 2020 and 24M USD for 2019.

How many employees does Dicerna have?

Dicerna has 302 employees.

What sector is Dicerna in?

Dicerna is a life science company.

When was Dicerna founded?

Dicerna was founded in 2006.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 397 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 351 by strategics.

Dicerna

Dicerna Pharmaceuticals, Inc.

75 Hayden Avenue,
Lexington, Massachusetts 02421
United States,
(617) 621-8097
www.dicerna.com

Dicerna is a biopharmaceutical company focused on discovering, developing, and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to silence selectively genes that cause or contribute to disease. Using proprietary RNAi technologies, GalXC and GalXC-Plus, Dicerna is committed to developing RNAi-based therapies with the potential to treat both rare and more prevalent diseases. Dicerna was founded in 2006 and is based in Lexington, Massachusetts.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # - - - - - - 0
Sell (0.2/yr) # - - 1 - - - 1
vol $240M $240M
  1

Most Recent M&A

Company Date Value Type
Dicerna - OXLUMO™ (lumasiran) 2021-04-08 240M USD Divestiture
Lexington, Massachusetts
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science - - 1 (100%) 240M (100%)
Total - - 1 $240M

By Geo

State/Country Buy Value Sell Value
United States - - 1 240M
  Massachusetts - - 1 240M
Total - - 1 $240M

Top M&A Advisors

Financial Deals
J. Wood Capital Advisors LLC
1
Legal Deals
Latham & Watkins
1

Deal Values

sell # Total
$100M to $1B 1 $240M
TOTAL $240M
Largest Dicerna - OXLUMO™ (lumasiran)
$240M (2021-04-08)

M&A Connections

Deals
Divested to
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 209,130
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.